Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Data access

Data access restrictions

Database access

Data licenses

Data upload

Enhanced publication

Institution responsibility type

Institution type

Keywords

PID systems

Provider types

Quality management

Repository languages

Software

Repository types

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 2 result(s)

Evaluated Nuclear Data File

ENDF

Subject(s)
Content type(s)
Country
Core nuclear reaction database contain recommended, evaluated cross sections, spectra, angular distributions, fission product yields, photo-atomic and thermal scattering law data, with emphasis on neutron induced reactions. The data were analyzed by experienced nuclear physicists to produce recommended libraries for one of the national nuclear data projects (USA, Europe, Japan, Russia and China). All data are stored in the internationally-adopted ENDF-6 format maintained by CSEWG.

PRO-ACT

Pooled Resource Open-Access ALS Clinical Trials Database

Subject(s)
Content type(s)
Country
The PRO-ACT platform houses the largest ALS clinical trials dataset ever created. It is a powerful tool for biomedical researchers, statisticians, clinicians, or anyone else interested in "Big Data." PRO-ACT merges data from existing public and private clinical trials, generating an invaluable resource for the design of future ALS clinical trials. The database will also contribute to the identification of unique observations, novel correlations, and patterns of ALS disease progression, as well as a variety of still unconsidered analyses. More than 600,000 people around them world are battling ALS. The disease strikes indiscriminately, and typically patients will die within 2-5 years following diagnosis. Currently, there are no effective treatments or a cure for ALS. Users of PRO-ACT are helping to accelerate the discovery, development, and delivery of ALS treatments, which will provide hope to patients and their families.